Printer Friendly

3,000,000 SHARES OF FOREST LABORATORIES, COMMON STOCK OFFERED AT $36-5/8 PER SHARE

                3,000,000 SHARES OF FOREST LABORATORIES,
               COMMON STOCK OFFERED AT $36-5/8 PER SHARE
    NEW YORK, Feb. 12 /PRNewswire/ -- Forest Laboratories, Inc. (AMEX: FRX), an international pharmaceutical manufacturer and marketer, announced today that an underwriting group led by Lehman Brothers, Donaldson Lufkin & Jenrette Securities Corporation and Morgan Stanley & Co. Incorporated is offering 3,000,000 shares of common stock by the company and selling shareholders to the public at a price of $36-5/8 per share.
    Net proceeds to the company from the sale of the 1,515,000 shares by the company will be used for working capital and general corporate purposes.
    This press release shall not constitute an offer to sell or the solicitation of an offer to buy.  The common stock is offered for sale by the underwriters solely pursuant to the Prospectus, a copy of which may be obtained from the Prospectus Department of Lehman Brothers, 250 West Street, New York, N.Y. 10013.
    -0-        2/12/92
    /CONTACT:  Kenneth E. Goodman, vice president-finance of Forest Laboratories, 212-421-7850/
    (FRX) CO:  Forest Laboratories Inc. ST:  New York IN:  MTC SU:  OFR SH -- NY024 -- 9123 02/12/92 09:52 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 12, 1992
Words:194
Previous Article:EQUIMARK ANNOUNCES HIGHLY SUCCESSFUL RIGHTS OFFERING
Next Article:UNIVERSAL PICTURES PROPOSES HALF-PRICE TICKET PROGRAM FOR FIRST RUN MOTION PICTURES
Topics:


Related Articles
FOREST LABORATORIES FILES REGISTRATION STATEMENT WITH THE SECURITIES AND EXCHANGE COMMISSION
FOREST LABORATORIES, INC. REVISES EXISTING SHARE RIGHTS PLAN AND DECLARES DIVIDEND DISTRIBUTION OF NEW PREFERRED SHARE PURCHASE RIGHTS
PATHOGENESIS CORPORATION INITIAL PUBLIC OFFERING OF 3 MILLION SHARES OF COMMON STOCK PRICED AT $10.00 PER SHARE
Barr Laboratories' Sales Climb 16% for Fiscal 1996; EPS Grows to $0.48 Record Revenues of $232 Million Reported
Forest Laboratories Reports Fourth Quarter and Fiscal 1997 Results
Anesta Reports 1998 Year-End Results.
ViroPharma Incorporated Reports Third Quarter Financial Results.
Abgenix Announces the Sale of 3,000,000 Shares of Common Stock in a Follow-On Public Stock Offering.
Cell Genesys Sells 840,000 Shares of Abgenix Common Stock As Part of Abgenix Follow-On Public Stock Offering.
Forest Laboratories Responds To Unsolicited Mini-Tender Offer.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters